{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:47:02Z","timestamp":1740167222576,"version":"3.37.3"},"reference-count":19,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2017.1532","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T09:46:46Z","timestamp":1512726406000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapy\u2011associated myelodysplastic syndrome with monosomy 7 arising in a Muir\u2011Torre Syndrome patient carrying SETBP1 mutation"],"prefix":"10.3892","author":[{"given":"David","family":"Ullman","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Wnukowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabe","family":"Koenig","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Mikhail","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pavlidakey","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4327-2861","authenticated-orcid":false,"given":"Deniz","family":"Peker","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"key20200713201652_b1-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"key":"key20200713201652_b2-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.suc.2017.01.009","article-title":"Hereditary colorectal cancer syndromes","volume":"97","author":"Wells","year":"2017","journal-title":"Surg Clin North Am"},{"key":"key20200713201652_b3-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T","article-title":"Hereditary nonpolyposis colorectal cancer (lynch syndrome I and II). I. Clinical description of resource","volume":"56","author":"Lynch","year":"1985","journal-title":"Cancer"},{"key":"key20200713201652_b4-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10689-005-8351-6","article-title":"Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations","volume":"4","author":"Bandipalliam","year":"2005","journal-title":"Fam Cancer"},{"key":"key20200713201652_b5-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20200713201652_b6-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.29615","article-title":"Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia","volume":"122","author":"Churpek","year":"2016","journal-title":"Cancer"},{"key":"key20200713201652_b7-mco-0-0-1532","first-page":"1","article-title":"Etiology and management of therapy-related myeloid leukemia","author":"Larson","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20200713201652_b8-mco-0-0-1532","first-page":"1","article-title":"Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia","author":"Pedersen-Bjergaard","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20200713201652_b9-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","article-title":"Cytogenetic features in myelodysplastic syndromes","volume":"87","author":"Haase","year":"2008","journal-title":"Ann Hematol"},{"key":"key20200713201652_b10-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin Oncol"},{"key":"key20200713201652_b11-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3904\/kjim.2012.27.1.115","article-title":"A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy","volume":"27","author":"Park","year":"2012","journal-title":"Korean J Intern Med"},{"key":"key20200713201652_b12-mco-0-0-1532","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1182\/blood.V89.5.1740","article-title":"Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines","volume":"89","author":"Hangaishi","year":"1997","journal-title":"Blood"},{"key":"key20200713201652_b13-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1365-2141.2000.02088.x","article-title":"Genetic instability in myelodysplastic syndrome: Detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations","volume":"109","author":"Maeck","year":"2000","journal-title":"Br J Haematol"},{"key":"key20200713201652_b14-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajh.23611","article-title":"Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression","volume":"89","author":"Hou","year":"2014","journal-title":"Am J Hematol"},{"key":"key20200713201652_b15-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.3324\/haematol.2014.108159","article-title":"SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms","volume":"99","author":"Fabiani","year":"2014","journal-title":"Haematologica"},{"key":"key20200713201652_b16-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ebiom.2016.04.005","article-title":"Comprehensive RNA analysis of the NF1 gene in classically affected NF1 affected individuals meeting NIH criteria has high sensitivity and mutation negative testing is reassuring in isolated cases with pigmentary features only","volume":"7","author":"Evans","year":"2016","journal-title":"EBioMedicine"},{"key":"key20200713201652_b17-mco-0-0-1532","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"key20200713201652_b18-mco-0-0-1532","unstructured":"AllanJMWildCPRollinsonSWillettEVMoormanAVDoveyGJRoddamPLRomanECartwrightRAMorganGJPolymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemiaProc Natl Acad Sci USA981159211597200110.1073\/pnas.19121119811553769"},{"key":"key20200713201652_b19-mco-0-0-1532","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V94.2.803","article-title":"Prevalence of the inactivating 609C->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia","volume":"94","author":"Larson","year":"1999","journal-title":"Blood"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:17:00Z","timestamp":1594667820000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1532","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}